Cardurion Pharma Stock
Cardurion Pharma is a clinical-stage biotechnology company dedicated to developing innovative treatments for cardiovascular diseases. Their research focuses on two key areas: inhibiting phosphodiesterase-9 (PDE9) to address various forms of heart failure, and targeting calcium/calmodulin-dependent protein kinase II (CaMKII) to treat both rare and common cardiovascular conditions. By advancing these novel therapeutic approaches, the company aims to improve patient outcomes in cardiovascular health.
Sign up for SecondMarket® to view the market and buy or sell Cardurion Pharma Stock
Buy + SellSee Cardurion Pharma Valuations + Financials
*Sample data + company shown for illustrative purposes only
Gain insights Into Cardurion Pharma Stock Valuation + Share Prices
View real-time Tape D® data on Cardurion Pharma stock including most recent valuation and historical share price information.
Are you an institutional investor or employee shareholder? Sign up to the SecondMarket trading platform.
Get Started
Cardurion Pharma Management Team
-
Board Member
Adam Koppel
-
Board Member
Edward Mathers
-
Chief Legal Officer
Steve Migausky
-
Board Member, President, CEO
Peter Lawrence
-
Board Member
Nicholas Downing
-
Chief Strategy Officer, Co-Founder, Board Member
Michael Mendelsohn
-
COO
Marcia D. Moore
-
Board Member
Evan Rachlin
-
Board Member
Daniel Lynch
-
Chief Medical Officer, Chief Scientific Officer
Howard K. Surks
-
Board Member
Ron Renaud
-
Chief Business Officer
Charlotte Newman
-
Board Member
Emma Reeve
-
Board Member
Jeb Keiper
-
CFO
Elizabeth Radcliffe
Learn More About Cardurion Pharma Stock
Buy Cardurion Pharma Stock
01Cardurion Pharma stock does not trade on public stock exchanges. Cardurion Pharma stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Cardurion Pharma stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Sell Cardurion Pharma Stock
02Cardurion Pharma Stock does not trade on public stock exchanges. In order to sell Cardurion Pharma shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Cardurion Pharma Stock Price
03Cardurion Pharma does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the Tape D™ database from Nasdaq Private Market, you can view Cardurion Pharma share price and other valuable private market data.
Read more about secondary market private company stock prices:
Cardurion Pharma Stock Ticker Symbol
04There is no ticker symbol for Cardurion Pharma stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Criteria to Sell Cardurion Pharma Stock
05Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Cardurion Pharma stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Criteria to Buy or Invest in Cardurion Pharma Stock
06Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Cardurion Pharma stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Cardurion Pharma Stock Settlement
07Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Cardurion Pharma IPO
08Cardurion Pharma is a private company and has not had an IPO. There is currently no Cardurion Pharma IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to Cardurion Pharma IPO.
Learn more about Tape D™ private company stock data for institutional investors on the on the Tape D™ Product Page.
Sign up for SecondMarket® to view the market and buy or sell Cardurion Pharma Stock
Buy + Sell*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.
